Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Buzzi

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Journal of Vascular Research|February 29, 2020
Determining the Optimal Normalization Factor of Different Target Arteries for ex vivo Vascular Function Experiments: A New Standardized ProcedureMichael Hugelshofer, Jeremy W Deuel, Raphael M Buzzi, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
t(8;14)(q11;q32) in acute lymphoid leukemia: description of two casesN Testoni, A Zaccaria, G Martinelli, et al.
Gynecologic and Obstetric Investigation|January 1, 1994
Epidermal growth factor stimulation of lecithin release by human amnionF Vesce, C Biondi, M E Ferretti, et al.
Free Radical Biology & Medicine|November 18, 2021
Spatial transcriptome analysis defines heme as a hemopexin-targetable inflammatoxin in the brainRaphael M Buzzi, Kevin Akeret, Nina Schwendinger, et al.
The Review of Scientific Instruments|August 2, 2013
Direct magnetocaloric characterization and simulation of thermomagnetic cyclesG Porcari, M Buzzi, F Cugini, et al.
Leukemia & Lymphoma|January 1, 1993
Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patientsG Martinelli, A Zaccaria, P Farabegoli, et al.
Transplantation Proceedings|September 27, 2005
Fresh and cryopreserved arterial homografts: immunological and clinical resultsM Mirelli, M Buzzi, G Pasquinelli, et al.
Cancer|May 15, 1990
Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotypeF Lauria, D Raspadori, R Foa, et al.
Nature|July 10, 2024
Magnetic field expulsion in optically driven YBa<sub>2</sub>Cu<sub>3</sub>O<sub>6.48</sub>S Fava, G De Vecchi, G Jotzu, et al.
Haematologica|September 1, 1988
The usefulness of routine immunological monitoring during the remission phase in acute lymphoblastic leukemiasA Bontadini, M Gobbi, P L Tazzari, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Journal of Vascular Research|February 29, 2020
Determining the Optimal Normalization Factor of Different Target Arteries for ex vivo Vascular Function Experiments: A New Standardized ProcedureMichael Hugelshofer, Jeremy W Deuel, Raphael M Buzzi, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
t(8;14)(q11;q32) in acute lymphoid leukemia: description of two casesN Testoni, A Zaccaria, G Martinelli, et al.
Gynecologic and Obstetric Investigation|January 1, 1994
Epidermal growth factor stimulation of lecithin release by human amnionF Vesce, C Biondi, M E Ferretti, et al.
Free Radical Biology & Medicine|November 18, 2021
Spatial transcriptome analysis defines heme as a hemopexin-targetable inflammatoxin in the brainRaphael M Buzzi, Kevin Akeret, Nina Schwendinger, et al.
The Review of Scientific Instruments|August 2, 2013
Direct magnetocaloric characterization and simulation of thermomagnetic cyclesG Porcari, M Buzzi, F Cugini, et al.
Leukemia & Lymphoma|January 1, 1993
Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patientsG Martinelli, A Zaccaria, P Farabegoli, et al.
Transplantation Proceedings|September 27, 2005
Fresh and cryopreserved arterial homografts: immunological and clinical resultsM Mirelli, M Buzzi, G Pasquinelli, et al.
Cancer|May 15, 1990
Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotypeF Lauria, D Raspadori, R Foa, et al.
Nature|July 10, 2024
Magnetic field expulsion in optically driven YBa<sub>2</sub>Cu<sub>3</sub>O<sub>6.48</sub>S Fava, G De Vecchi, G Jotzu, et al.
Haematologica|September 1, 1988
The usefulness of routine immunological monitoring during the remission phase in acute lymphoblastic leukemiasA Bontadini, M Gobbi, P L Tazzari, et al.
Pageof 13